Gastrointestinal Diseases: Clinical Trials

26,544 trials for Gastrointestinal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12237 completed, 5160 unknown, 3545 recruiting, 1969 terminated. 8011 Not applicable, 6031 Phase 2, 3156 Phase 1, 2530 Phase 3, 1110 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8011Completed 3687, Unknown 1663, Recruiting 1087, Not yet recruiting 498, Terminated 446, Active not recruiting 260, Withdrawn 232, Enrolling by invitation 103, Suspended 35
Phase 26031Completed 2469, Unknown 1117, Recruiting 847, Terminated 692, Active not recruiting 323, Not yet recruiting 305, Withdrawn 234, Suspended 28, Enrolling by invitation 16
Phase 13156Completed 1484, Recruiting 458, Terminated 417, Unknown 348, Active not recruiting 190, Withdrawn 116, Not yet recruiting 115, Suspended 18, Enrolling by invitation 10
Phase 32530Completed 1249, Unknown 462, Recruiting 284, Terminated 248, Active not recruiting 128, Not yet recruiting 84, Withdrawn 64, Enrolling by invitation 6, Suspended 5
Phase 41110Completed 587, Unknown 206, Terminated 101, Recruiting 84, Not yet recruiting 59, Withdrawn 51, Active not recruiting 18, Enrolling by invitation 3, Suspended 1
Early Phase 1254Completed 77, Unknown 63, Recruiting 35, Terminated 22, Not yet recruiting 21, Withdrawn 13, Active not recruiting 11, Enrolling by invitation 9, Suspended 3

Follow Gastrointestinal Diseases: new trials by email Literature Review of Gastrointestinal Diseases trials Research Report on Gastrointestinal Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam - Ulcerative Colitis
Phase 4Not yet recruitingBausch Health Americas, Inc.1002029-06-012026-10-06
Bilio-pancreatic Complications of Congenital Duodenal Obstructions
duodenal atresia - Duodenal Obstruction
Not yet recruitingUniversity Hospital, Angers4502028-12-012026-02-10
Adaptive Neoadjuvant Therapy for Esophageal Cancer
Neoadjuvant concurrent chemoradiotherapy - Esophageal Carcinoma, Neoadjuvant Therapy
Not applicableEnrolling by invitationCancer Hospital Chinese Academy of Medical Science, Shenzhen Center432028-03-012025-05-25
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
Shared Decision Making using a Patient Decision Aid. - Shared Decision Making, Colonic Polyp
Phase 2Not yet recruitingVejle Hospital1102028-02-012026-04-30
AI-Enabled Mobile App for Safe Eating in Older Adults With Dysphagia
AI-Enabled Mobile Application plus Standard Care, Standard Dysphagia Education - Deglutition Disorders, Dysphagia
Not applicableNot yet recruitingKAM Chi Shan Anna3322028-01-012026-09-23
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer
CA102N, TAS-102, Bevacizumab - Metastatic Colorectal Cancer
Phase 2SuspendedHoly Stone Healthcare Co., Ltd1002027-12-012026-09-18
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
intravoxel incoherent motion magnetic resonance imaging - Rectal Neoplasms, Prognosis
Not yet recruitingSichuan Cancer Hospital and Research Institute4002027-11-012025-12-08
Liver Steatosis in Pediatric CD Patients
Gluten-free diet - Celiac Disease in Children, Non-Alcoholic Fatty Liver Disease
RecruitingUniversity of Palermo912027-11-012026-05-01
Oral Fosamprenavir for GERD
Fosamprenavir Calcium 700 MG Oral Tablet, Placebo - Refractory Gastroesophageal Reflux Disease, Gastroesophageal Reflux Disease
Phase 2Not yet recruitingMedical College of Wisconsin602027-10-012026-09-10
DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure
blood sampling, Blood sampling - Renal Impairment, Digestive Cancers
Not yet recruitingCentre Hospitalier Universitaire de Besancon7422027-10-012026-11-02
A Mindfulness-based Stress Reduction Program for IBD
Mindfulness based stress reduction, Active Control - Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Not applicableNot yet recruitingNova Scotia Health Authority702027-09-012026-09-08
Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial
Expiratory muscle strength training (EMST), Standard of Care Dysphagia Treatment, Intensive Dysphagia Treatment - Dysphagia, Critical Illness
Not applicableNot yet recruitingVanderbilt University Medical Center1202027-07-012026-10-14
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Digital Mind Body Intervention mobile application - Crohn's Disease, Ulcerative Colitis
Not applicableNot yet recruitingMontefiore Medical Center402027-07-012026-09-14
Parent Implemented Oral Nutrition, Eating, and Esophageal Reflexes Reintegration Protocol: RCT
PIONEER Protocol - Deglutition Disorders in Infants, Chronic Tube Feeding in Hospitalized Infants
Not applicableNot yet recruitingNationwide Children's Hospital1302027-07-012026-08-28
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Pembrolizumab and either Capcecitabine + Oxaliplatin or Oxaliplatin+Leucovorin + 5-fluorouracil - Gastric Cancer, Gastroesophageal-junction Cancer
Phase 3Not yet recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.8202027-06-302026-09-29
Analysis of the Role of the Microbiota in Diverticular Disease
Diverticular Disease of Colon, Acute Diverticulitis
Not yet recruitingHospital of Navarra2852027-06-012026-09-02
Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
Adapted Physical Activity, Usual Care - Inflammatory Bowel Diseases (IBD), Fatigue
Not applicableNot yet recruitingUniversity Hospital, Grenoble1202027-06-012026-09-11

Showing 20 of 26544. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (6126)  ·  Stomach Neoplasms (3179)  ·  Colonic Neoplasms (2382)  ·  Rectal Neoplasms (2239)  ·  Crohn Disease (1947)  ·  Esophageal Neoplasms (1843)  ·  Colitis, Ulcerative (1793)  ·  Inflammatory Bowel Diseases (1548)  ·  Gastroesophageal Reflux (1174)  ·  Breast Neoplasms (1017)  ·  Irritable Bowel Syndrome (995)  ·  Neoplasms (969)  ·  Deglutition Disorders (836)  ·  Pancreatic Neoplasms (817)  ·  Carcinoma, Non-Small-Cell Lung (731)

Broader conditions

Digestive System Diseases (26377)  ·  Intestinal Diseases (17032)  ·  Digestive System Neoplasms (14392)  ·  Neoplasms by Site (14370)  ·  Neoplasms (14114)  ·  Gastrointestinal Neoplasms (13766)  ·  Colonic Diseases (10791)  ·  Intestinal Neoplasms (9352)  ·  Rectal Diseases (8696)  ·  Gastroenteritis (5526)  ·  Pathological Conditions, Signs and Symptoms (5432)  ·  Esophageal Diseases (5100)  ·  Stomach Diseases (3991)  ·  Colorectal Neoplasms (3233)

Interventions

Oxaliplatin (1007)  ·  Fluorouracil (964)  ·  Capecitabine (784)  ·  Leucovorin (692)  ·  Irinotecan (634)  ·  Bevacizumab (601)  ·  Cetuximab (430)  ·  Cisplatin (430)  ·  Radiotherapy (396)  ·  Paclitaxel (325)  ·  pembrolizumab (305)  ·  Drug Therapy (253)  ·  Docetaxel (222)  ·  Surgical Procedures, Operative (217)  ·  Nivolumab (196)

Sponsors

National Cancer Institute (NCI) (326)  ·  Fudan University (256)  ·  Mayo Clinic (243)  ·  AstraZeneca (213)  ·  Sun Yat-sen University (210)  ·  M.D. Anderson Cancer Center (193)  ·  Assiut University (183)  ·  Takeda (175)  ·  Memorial Sloan Kettering Cancer Center (172)  ·  Chinese University of Hong Kong (155)  ·  Pfizer (145)  ·  National Taiwan University Hospital (136)  ·  Hoffmann-La Roche (131)  ·  Assistance Publique - Hôpitaux de Paris (129)  ·  Massachusetts General Hospital (128)

Countries

United States (8026)  ·  China (4263)  ·  France (2032)  ·  Italy (1570)  ·  United Kingdom (1545)  ·  Canada (1534)  ·  South Korea (1428)  ·  Germany (1383)  ·  Spain (1371)  ·  Netherlands (1022)  ·  Belgium (1008)  ·  Australia (756)  ·  Japan (751)  ·  Poland (735)  ·  Denmark (734)

Top investigators

Nieto Luis, Master (22)

Results publications

PMID 40243391, PMID 33538338, PMID 35623069, PMID 24275240, PMID 40357993, PMID 26808342, PMID 22825366, PMID 36306483, PMID 40013523, PMID 40341124, PMID 15496622, PMID 24533607, PMID 25430806, PMID 29380251, PMID 32445184, PMID 35588252, PMID 37162250, PMID 19735233, PMID 30207593, PMID 15273542, PMID 25625764, PMID 25694210, PMID 26893500, PMID 27144617, PMID 31268130, PMID 33356421, PMID 35648151, PMID 36124702, PMID 37368103, PMID 40340830, PMID 20354937, PMID 20728210, PMID 21129076, PMID 22646630, PMID 26049686, PMID 26187751, PMID 28712102, PMID 29850873, PMID 30476584, PMID 30679026, PMID 30739254, PMID 31077827, PMID 31378656, PMID 31599001, PMID 32816215, PMID 32816630, PMID 33684552, PMID 35792493, PMID 36342120, PMID 36526796

NIH funding

2023 (148), 2017 (98), 2025 (98), 2019 (83), 2016 (82), 2015 (79), 2018 (77), 2014 (65), 2009 (55), 2008 (51), P30CA033572 (37), P30CA015083 (30), P30CA014089 (25), P30CA016672 (24), U10CA032102 (22)